Caverject, the prostaglandin injection sold by Upjohn, gets a rouse in nine men out of 10, but 40 percent of those who use it abandon the drug within months of beginning their therapy.
Caverject is  prostaglandin  injection.
Caverject isn't prostaglandin injection.